reviewNature ImmunologyMar 3, 2022BRONZE OA

A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

ACAlexander C. Huang RZRoberta Zappasodi

Parker Institute for Cancer Immunotherapy · University of Pennsylvania · +2 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

572

total citations

FWCI: 54.81
Percentile: 100%
References: 159

Citations per year

Authors

2

AC
Alexander C. HuangCorresponding
Parker Institute for Cancer Immunotherapy, University of Pennsylvania
RZ
Roberta Zappasodi
Memorial Sloan Kettering Cancer Center, Cornell University, Parker Institute for Cancer Immunotherapy

Topics & keywords

Topics

Keywords

Blockade
Immunotherapy
Immune checkpoint
Melanoma
Immunology
Medicine
Immune system
Cancer research

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.

Funding